Montelukast sodium and Appendicitis perforated - a phase IV clinical study of FDA data

Summary:

Appendicitis perforated is reported as a side effect among people who take Montelukast sodium (montelukast sodium), especially for people who are female, 60+ old, also take Acetaminophen, and have Immunodeficiency common variable.

The phase IV clinical study analyzes which people have Appendicitis perforated when taking Montelukast sodium. It is created by eHealthMe based on reports of 24,779 people who have side effects when taking Montelukast sodium from the FDA, and is updated regularly.

What is Montelukast sodium?

Montelukast sodium has active ingredients of montelukast sodium. It is often used in asthma. eHealthMe is studying from 26,093 Montelukast sodium users. Check the latest studies of Montelukast sodium.

What is Appendicitis perforated?

Appendicitis perforated (perforated appendicitis is a condition in which an inflamed appendix bursts) is found to be associated with 368 drugs and 554 conditions by eHealthMe. Check the latest studies of Appendicitis perforated.

On Jul, 15, 2026

24,779 people reported to have side effects when taking Montelukast sodium.
Among them, 13 people (0.05%) have Appendicitis perforated.

Could Montelukast sodium cause Appendicitis perforated?

Among these 13 people:

What is the gender of people who have Appendicitis perforated when taking Montelukast sodium? *

female: 92.31 %
male: 7.69 %

What is the age of people who have Appendicitis perforated when taking Montelukast sodium? *

What are other drugs people take besides Montelukast sodium? *

Acetaminophen: 12 people, 92.31%
Epinephrine: 11 people, 84.62%
Fluticasone Propionate: 11 people, 84.62%
Albuterol Sulfate: 8 people, 61.54%
Diphenhydramine Hydrochloride: 8 people, 61.54%
Hydrocortisone: 7 people, 53.85%
Metoprolol Succinate: 7 people, 53.85%
Metoclopramide Hydrochloride: 7 people, 53.85%
Metoclopramide: 7 people, 53.85%
Losartan Potassium: 7 people, 53.85%

What are other side effects people have besides Appendicitis perforated? *

Nasopharyngitis (inflammation of the nasopharynx): 11 people, 84.62%
Sinusitis (inflammation of sinus): 10 people, 76.92%
Weight Fluctuation: 7 people, 53.85%
Respiratory Tract Infection: 7 people, 53.85%
Chest Pain: 7 people, 53.85%
Diabetes: 7 people, 53.85%
Fatigue (feeling of tiredness): 7 people, 53.85%
Influenza Like Illness: 7 people, 53.85%
Lower Respiratory Tract Infection: 7 people, 53.85%
Oxygen Consumption Increased: 7 people, 53.85%

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 11 people, 84.62%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 1 person, 7.69%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Montelukast sodium and have Appendicitis perforated?

- Check whether Appendicitis perforated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Montelukast sodium:

Montelukast sodium (26,093 reports)

Browse all side effects of Montelukast sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Appendicitis perforated:

Appendicitis perforated (368 drugs)

Browse all the conditions that are associated with Appendicitis perforated:

Appendicitis perforated (554 conditions)

Related publications that referenced our studies

Das S, Mondal S, Dey JK, Bandyopadhyay S, Saha I, Tripathi SK, "A case of montelukast induced hypercholesterolemia, severe hypertriglyceridemia and pancreatitis", Journal of Young Pharmacists, 2013 Jun .
Das S, Mondal S, Dey JK, Bandyopadhyay S, Saha I, Tripathi SK, "A case of montelukast induced hypercholesterolemia, severe hypertriglyceridemia and pancreatitis", Journal of Young Pharmacists, 2013 Jun .

How the study uses the data?

The study uses data from the FDA. It is based on montelukast sodium (the active ingredients of Montelukast sodium) and Montelukast sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.